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Aims As a sine qua non for arterial wall physiology, local hemodynamic forces such as endothelial shear stress (ESS) may
influence long-term vessel changes as bioabsorbable scaffolds dissolve. The aim of this study was to perform serial
computational fluid dynamic (CFD) simulations to examine immediate and long-term haemodynamic and vascular
changes following bioresorbable scaffold placement.
...................................................................................................................................................................................................
Methods
and results
Coronary arterial models with long-term serial assessment (baseline and 5 years) were reconstructed through
fusion of intravascular optical coherence tomography and angiography. Pulsatile non-Newtonian CFD simulations
were performed to calculate the ESS and relative blood viscosity. Time-averaged, systolic, and diastolic results
were compared between follow-ups. Seven patients (seven lesions) were included in this analysis. A marked heter-
ogeneity in ESS and localised regions of high blood viscosity were observed post-implantation. Percent vessel area
exposed to low averaged ESS (<1 Pa) significantly decreased over 5 years (15.92% vs. 4.99%, P<0.0001) whereas
moderate (1–7 Pa) and high ESS (>7 Pa) did not significantly change (moderate ESS: 76.93% vs. 80.7%, P=0.546;
high ESS: 7.15% vs. 14.31%, P=0.281), leading to higher ESS at follow-up. A positive correlation was observed
between baseline ESS and change in lumen area at 5 years (P<0.0001). Maximum blood viscosity significantly
decreased over 5 years (4.30 ± 1.54 vs. 3.21± 0.57, P=0.028).
...................................................................................................................................................................................................
Conclusion Immediately after scaffold implantation, coronary arteries demonstrate an alternans of extremely low and high ESS
values and localized areas of high blood viscosity. These initial local haemodynamic disturbances may trigger fibrin
deposition and thrombosis. Also, low ESS can promote neointimal hyperplasia, but may also contribute to appro-
priate scaffold healing with normalisation of ESS and reduction in peak blood viscosity by 5 years.
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Introduction
The fundamental concept of a stent and its complications has not
changed greatly since pioneering work in the early 20th century.1
The technology underlying these devices, however, has undergone
great and rapid advances that seem, perhaps, to be accelerating.
Despite excellent clinical outcomes with current generation of
metallic drug-eluting stents, their permanent nature remains a theo-
retical limitation. In that sense, the adoption of bioresorbable materi-
als is one recent leap forward in stent technology. The ideal
bioresorbable stent is meant to fulfil a temporary function as a vascu-
lar scaffold to aid vessel healing and stabilisation, and then disappear.
The Absorb Bioresorbable Vascular Scaffold (BVS, Abbott
Vascular, Santa Clara, CA, USA) has been the most implanted and
studied bioresorbable scaffold. The longest-term clinical data cur-
rently available indicates 5-year outcomes similar to standard compa-
rator metallic drug-eluting stents.2,3 Resorption of the Absorb may
also be accompanied by a partial and gradual return of normal vaso-
motion, late lumen enlargement, and plaque stabilisation.4–8
However, recent evidence from larger trials shows that while rare,
late thrombosis occurs more frequently with the Absorb scaffold.9–11
There remain many unanswered questions regarding the mechanisms
of late scaffold complications, but certain clues may lie in the dynam-
ics of blood flow after scaffolding.
Fluid shear stress exerted by blood flow directly regulates vascular
physiology and pathology.12,13 Changes in arterial geometry induced
by stent or scaffold placement can significantly change blood flow
throughout the vessel,14,15 thereby altering the macro-level shear
stress distribution. Individual stent struts may themselves disturb flow
at an even smaller scale near the endothelium,16–19 creating so-called
micro-level disturbances. After implantation, such macro- and micro-
level flow disturbances may have repercussions not only for the
development of scaffold thrombosis and restenosis, but also for
appropriate neointimal healing and vessel remodelling.
The aim of this study was to perform serial high-fidelity computa-
tional fluid dynamic (CFD) simulations to examine immediate and
long-term haemodynamic and vascular changes following bioresorb-
able scaffold placement.
Methods
Patient selection and study design
Patients with serial imaging from the ABSORB Cohort B clinical trial were
retrospectively identified for further computational analysis. The original
study design and protocol have been previously described.20 Patients
underwent serial invasive imaging with coronary angiography and optical
coherence tomography (OCT) immediately after scaffold implantation
and again at 5 years.
Exclusion criteria were lack of two angiographic views separated by
>25, excessive vessel foreshortening, suboptimal OCT images, and side
branches >2mmwithin the scaffold which prohibited 3D reconstruction.
Angiography andOCT images from each time point were fused to recon-
struct 3D models of the scaffolded artery at baseline and 5 years.
Computational fluid dynamic analysis was then performed to calculate
endothelial shear stress (ESS) and local blood viscosity at baseline and
5 years.
Image acquisition and data analysis
Optical coherence tomography is an intravascular imaging technique pro-
viding high-resolution (10–20lm) cross-sectional images of coronary
arteries and scaffolds.21 Optical coherence tomography was performed
immediately after scaffold implantation and at 5 years in all treated coro-
nary arteries using a frequency-domain OCT system (C7-XR or C8XR
OCT Intravascular Imaging System; St. Jude Medical, St. Paul, MN, USA).
All image acquisitions were performed using non-occlusive contrast flush-
ing according to standard guidelines.21 Angiography was performed as
previously described.20
Three-dimensional arterial reconstruction
For each time point, OCT and angiography were fused to reconstruct
patient-specific 3D models of the scaffolded artery at baseline and 5 years
(Figure 1).22 Briefly, dual plane end-diastolic angiographic images (orthogonal
views >25 difference) were used to extract the 3D luminal centreline
(QAngio XA 3D, Medis Specials Bv, Netherlands). The radiopaque scaffold
markers and side branches were used as landmarks to co-register angiogra-
phy with OCT. The OCT lumen and scaffold contours were semi-
automatically detected (QCU-CMS v4.69, LKEB, Leiden University,
Netherlands). The contours were placed onto the angiographic centreline
using scaffold markers and vessel landmarks to correct the rotational and
longitudinal orientation of the OCT frames (MATLAB R2015b, Mathworks
Inc., Natick, MA, USA), and the baseline and 5-year scaffolded vessel surfaces
were generated (Meshlab, Visual Computing Lab ISTI-CNR, Pisa, Italy).23
Computational fluid dynamic simulation
Each reconstruction was discretised into approximately 30 million tetra-
hedral elements using ICEM CFD v15.0 (ANSYS Inc., Canonsburg, PA,
USA). Computational fluid dynamic analysis was accomplished through
direct solution of the incompressible Navier–Stokes equations describing
fluid motion (OpenFOAM-2.1.1, OpenCFD Ltd, ESI group, Bracknell,
UK). A time-varying (pulsatile) parabolic velocity profile with a mean inlet
flow of 1.3 cc/s was applied at the inlet. The arterial wall was considered
rigid with a no-slip boundary and a non-specific distal vascular resistance
was applied at the outlet. Blood density was assumed 1060kg/m3 and
haematocrit 45%. Non-Newtonian blood behaviour was modelled using
the Quemada equation, in which viscosity varies depending on shear rate
and haematocrit.24 OpenFOAM was run on the Victorian Life Sciences
Computation Initiative (VLSCI) supercomputer consisting of 1024 IBM
Blue Gene/Q CPUs at 1.6GHz (IBM Research, Australia).
Endothelial shear stress was calculated as the product of viscosity and
velocity gradient (shear rate) at the wall. For quantitative calculations ESS
was classified as low (<1Pa), moderate (1–7 Pa), or high (>7Pa) (see
Supplementary material online, Methods).25–27 Percent lumen area
exposed to low, moderate, and high ESS at systolic, diastolic, and time-
averaged flow was determined at baseline and 5 years. In order to assess
the change in lumen dimensions, the baseline and 5-year arterial recon-
structions were matched by using the scaffold markers and anatomical
landmarks. The impact of baseline ESS on the change in lumen area was
investigated.
Due to its shear-thinning properties, blood exhibits higher viscosity at
low shear rates and approaches a constant low viscosity at high shear
rates. Computational fluid dynamic simulations using a Newtonian model
of blood behaviour assume that shear rate is high enough that viscosity is
constant (0.0035 Pa s). However, the non-Newtonian model used in this
study allowed direct calculation of local blood viscosity,24 which was
expressed as a ratio of non-Newtonian to constant Newtonian viscos-
ity28,29 and henceforth referred to as relative viscosity. Maximum relative
blood viscosity was determined at systolic, diastolic, and time-averaged
flow at baseline and 5 years.
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Statistical analysis
Continuous variables were reported as mean (standard deviation) if they
followed a Gaussian distribution. Binary variables were reported as
counts and percentages. Changes in ESS between baseline and 5 years
were compared with a generalized linear mixed-effect model with a ran-
dom intercept. To examine the association between baseline shear stress
and changes in luminal area a one-level hierarchical linear model was
used. No formal hypothesis testing was planned. A Wilcoxon rank sum
test was used to evaluate the change in relative blood viscosity. All P-val-
ues were two-sided. However, the P-values presented are exploratory
analyses only, and should therefore be interpreted cautiously. A non-
parametric Robust method (CLSI C28-A3) was used to calculate 95%
confidence interval.30 Data analysis was performed using SPSS, version 24
(Chicago, IL, USA).
Results
Seven patients (seven lesions) fulfilled the study criteria and were
included in the present analysis. The scaffold was implanted the left
anterior descending coronary artery (5), left circumflex artery (1),
and right coronary artery (1). Patient characteristics are demon-
strated in Table 1. Procedural characteristics are shown in Table 2.
None of the patients developed adverse clinical events including
death, myocardial infarction, revascularisation, or scaffold thrombosis
during 5 years of clinical observation (see Supplementary material
online, Table S1).
Since peak coronary flow occurs during diastole, the vessel was
exposed to predominantly high ESS (Take home figure A and C)
without evidence of micro-recirculation. During systole, a rapid drop
in coronary flow results in exposure to very low ESS (Take home
figure B and D) and, due to the steep negative flow gradient, unmasks
micro-recirculation of blood between scaffold struts at baseline
(Take home figure B1 and B2). By 5 years, ESS has homogenised to
Figure 1 Three-dimensional arterial models were reconstructed from the fusion of angiography and optical coherence tomography. (A, E)
Angiography was used to extract the vessel centreline in the scaffolded segment (between white lines). (B, C, F, G) Optical coherence tomography
images were used to generate the detailed lumen and scaffold surface. Representative optical coherence tomography images show the same loca-
tions at baseline and 5 years (green and orange arrows). (D, H) Computational fluid dynamic simulations were performed to calculate endothelial
shear stress and local blood viscosity. ESS, endothelial shear stress.
Table 1 Baseline characteristics of the studied popula-
tion (n5 7, lesions57)
Age (years) 62± 9
Male 4 (57)
Hypertension 3 (43)
Hypercholesterolaemia 5 (71)
Diabetes mellitus 0 (0)
Current smoking 1 (14)
Prior percutaneous coronary intervention 2 (29)
Prior myocardial infarction 2 (29)
Stable angina 5 (71)
Unstable angina 1 (14)
Silent ischaemia 0 (0)
Treated vessel
Left anterior descending artery 5 (71)
Left circumflex artery 1 (14)
Right coronary artery 1 (14)
Ramus intermedius 0 (0)
Values are mean± standard deviation or n (%).
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.. more physiological values and systolic micro-recirculation has dissi-
pated (Take home figure D1 and D2).
Quantitative measurements demonstrate that although ESS distri-
bution varied considerably through the cardiac cycle, the mean per-
cent lumen area exposed to ESS <1Pa significantly decreased
between baseline and 5 years during diastolic, systolic, and time-
averaged conditions (diastole: 6.90 vs. 2.78%, P=0.008; systole: 53.31
vs. 38.37%, P=0.042; time-averaged: 15.92 vs. 4.99%, P<0.0001)
(Table 3). Although individual cases demonstrated slightly different
patterns of increases in moderate and high ESS (Figure 2) (see
Supplementary material online, Table S2), overall mean vessel expo-
sure to moderate and high ESS did not significantly change over 5
years in diastolic, systolic, or time-averaged flow conditions (Table 3).
Figure 3 represents the relationship between post-implantation
ESS and the change in lumen area over 5 years. A positive association
was observed (y= 0.32x–1.49; P<0.0001), indicating that higher
baseline ESS values after scaffold implantation were correlated with
an increase in lumen area. A serial point-by-point analysis was also
performed to investigate the change in lumen radius, and demon-
strated a similar qualitative relationship to baseline ESS (Figure 4).
High blood viscosity was apparent in two broadly distinctive
regions: at the centre of the artery where shear rate is low but blood
velocity is high, and at specific locations near the lumen surface where
both shear rate and blood velocity are low. Notably, near-wall
regions of high blood viscosity were observed in the vicinity of
Take home ﬁgure Pulsatile computational fluid dynamic simulation provides detailed local haemodynamics in diastole and systole. (A, B) At
baseline, the vessel has a corrugated appearance arising from high endothelial shear stress on top of scaffold struts and low endothelial shear stress in
between. (C, D) At 5 years, only broad swaths of low, moderate, and high endothelial shear stress remain. (B1, D1) Cut-plane views of the area within
the dashed white box in B and D, respectively, demonstrate laminar flow at the centre of the artery but micro-recirculation near the wall. By 5 years
systolic micro-recirculation has been eliminated. (B2, D2) Enlarged view of area within the dashed white box in B1 and D1, respectively, show that
micro-recirculation occurs only at baseline between scaffold struts. ESS, endothelial shear stress.
.................................................................................................
Table 2 Procedural characteristics
n5 7, lesions57
ACC/AHA lesion class
A 0 (0)
B1 5 (71)
B2 2 (29)
C 0 (0)
Pre-dilatation 7/7 (100)
Mean pre-dilatation pressure (atm) 11.77 ± 2.56
Diameter of scaffolds (mm) 3.00 ± 0.0
Expected scaffold diameter (mm) 3.26 ± 0.10
Total length of study devices (mm) 18.0 ± 0.0
Nominal scaffold area (mm2) 7.07 ± 0.0
Expected scaffold area (mm2) 8.37 ± 0.53
Mean deployment pressure (atm) 13.00 ± 3.01
Post-dilatation 4/7 (57)
Mean post-dilatation pressure (atm) 17.64 ± 5.28
Procedural complications 0/7 (0)
Clinical device success 7/7 (100)
Clinical procedure success 7/7 (100)
Values are mean ± standard deviation or n (%).
ACC, American College of Cardiology; AHA, American Heart Association.
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scaffold struts (Figure 5), corresponding to locations of micro-
recirculation and low ESS.
Quantitative analysis of all seven cases demonstrated an approxi-
mately 35% higher time-averaged blood viscosity throughout the
arteries than is conscribed by the Newtonian model. Although mean
viscosity did not change, maximum relative viscosity significantly
decreased over 5 years (systole: 8.84 vs. 5.33, P=0.043; diastole: 4.46
vs. 3.18, P=0.063; time-averaged: 4.30 vs. 3.21, P=0.028) (Table 4).
Like ESS, viscosity also fluctuated considerably throughout the car-
diac cycle, peaking in systole for all cases at both baseline and 5 years
(see Supplementary material online, Table S3). Remarkably, in Cases
1, 5, and 7 the maximum relative viscosity approached a 10-fold
increase in some locations at baseline.
Discussion
The high fidelity CFD simulations conducted in this study revealed
that haemodynamics in scaffolded coronary arteries are marked by
wide fluctuation in ESS throughout the cardiac cycle, resulting in tran-
sient micro-recirculation, and pockets of high blood viscosity in the
scaffolded region that largely disappear as the scaffold dissolves. This
process was accompanied by vessel exposure to more physiological
levels of ESS, reduced peak blood viscosity, and late lumen enlarge-
ment over 5 years.
Figure 2 Histogram demonstrating percent of the lumen area
exposed to various levels of endothelial shear stress at baseline and
5 years for each case. ESS, endothelial shear stress.
............................................................... ............................................................... ................................................................
....................................................................................................................................................................................................................
Table 3 Pulsatility-dependent endothelial shear stress at baseline and 5 years, all cases combined
Systole Diastole Time-averaged
Baseline
(95% CI)
5 years
(95% CI)
P-
value
Baseline
(95% CI)
5 years
(95% CI)
P-
value
Baseline
(95% CI)
5 years
(95% CI)
P-
value
ESS <1 53.31
(14.23 to 102.61)
38.37
(-24.11 to 99.05)
0.042 6.9
(-5.02 to 17.74)
2.78
(-10.72 to 12.83)
0.008 15.92
(1.06 to 27.89)
4.99
(-10.42 to 18.16)
<0.0001
1< ESS <7 46.23
(-0.88 to 84.10)
58.98
(6.01 to 116.29)
0.067 68.79
(36.82 to 91.75)
61.28
(1.66 to 122.01)
0.434 76.93
(58.67 to 94.70)
80.7
(46.40 to 123.14)
0.546
ESS >7 0.46
(-1.65 to 2.03)
2.65
(0 to 9.89)
NS 24.31
(-6.06 to 58.17)
35.94
(-30.82 to 102.02)
0.218 7.15
(-8.16 to 20.21)
14.31
(-31.11 to 49.68)
0.281
Values are expressed as percent lumen area exposed to low, moderate, and high ESS.
CI, confidence interval; ESS, endothelial shear stress; NS, not significant.
Figure 3 Scatterplot of baseline endothelial shear stress vs. the
interval change in lumen area over 5 years for all cases combined,
coloured by the relative density of data points (yellow indicates high
density, blue indicates low density). Baseline and 5-year arterial
reconstructions were precisely aligned and compared on a frame-
by-frame basis. Higher baseline endothelial shear stress values are
correlated with an increase in lumen area over 5 years. ESS, endo-
thelial shear stress.
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.. Bioresorbable medical devices have gained exceptional attention
over recent years but there remain many unanswered questions
about how these devices perform over time. These questions have
been particularly relevant with the Absorb coronary scaffold, which
has been hampered by late scaffold thrombosis.2,10,11,31 The mecha-
nisms are thought to involve late scaffold dismantling and inflamma-
tion,8,32 but other factors governing scaffold outcomes could include
local blood flow dynamics.
Fluid dynamic phenomena of blood flow directly regulate vascular
biology and influence the development of atherosclerosis.12,13
Abnormally low and high ESS have been correlated with atheroscler-
otic plaque progression, vulnerability, and perhaps even disruption,
platelet activation, and subsequent thrombosis.33–36 Similarly,
changes in arterial geometry induced by stent or scaffold placement
can also significantly alter blood flow and ESS distribution at the strut
and vessel scale.37 Such post-intervention flow disturbances may
have repercussions for the development of scaffold thrombosis and
restenosis.15,18,38
In order to gain new insights into local haemodynamics within scaf-
folded arteries, this study employed serial OCT imaging over 5 years
as the basis for CFD analysis. Due to the use of pulsatile flow condi-
tions and a non-Newtonian model of blood behaviour, these simula-
tions are of unprecedented scope and detail. This methodology has
allowed several key observations.
Figure 4 After optimal alignment, baseline and 5-year arterial
reconstructions were compared on a point-by-point basis. A scat-
terplot of baseline endothelial shear stress vs. the interval change in
lumen radius over 5 years from a single representative case, col-
oured by density of data points (yellow indicates high density; blue
indicates low density). Qualitatively, higher baseline endothelial
shear stress values are correlated with an increase in lumen radius
at that point over 5 years. ESS, endothelial shear stress.
Figure 5 (A, B) Time-averaged endothelial shear stress within the scaffolded segment. (C, D) Longitudinal cut-plane view of the scaffolded segment,
with volume-rendered near-wall regions of high blood viscosity. The lumen surface is solid white in colour. Regions of red indicate relative viscosity
>1.4. (C) At baseline, regions of high viscosity localise to the inter-strut region and the distal segment of the curved artery. (C1) A closer view shows
that after implantation, high viscosity may extend over struts and further into the lumen (white arrowheads). (D, D1) By 5 years, a region of high vis-
cosity persists at the distal curvature, however, the inter-strut regions of high viscosity have largely disappeared.
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First, higher ESS values immediately after scaffold implantation are
significantly correlated with lumen enlargement by 5 years. Several
intravascular ultrasound based studies in native arteries and OCT-
based studies in scaffolded arteries suggest a similar relationship
between ESS and subsequent vessel change.36,39–42 Whether this
phenomenon is unique to polymeric bioresorbable devices is
unknown, but the consistent upward shift in ESS values observed in
this study may continue to push the balance toward positive
Glagovian remodelling and late lumen enlargement.8,43–45
Second, there is significant fluctuation in ESS and relative blood vis-
cosity throughout the cardiac cycle, indicating that coronary arteries
experience extreme absolute values and sudden shifts in local hae-
modynamics with each heartbeat. Exceptionally high ESS values iden-
tified in diastole are notable given the putative role of high ESS in
platelet activation, plaque destabilisation, and perhaps even rup-
ture.33,35,46 Conversely, the rapid drop in coronary flow at the onset
of systole unmasks micro-recirculation of blood between scaffold
struts, reflecting areas prone to momentary blood stagnation and
high viscosity in every cardiac cycle. In fact, after scaffold implantation
blood manifested up to a 10-fold increase in relative viscosity around
scaffold struts during systole. Some regions of high viscosity persisted
even in diastole.
Third, regardless of time point within the cardiac cycle, all cases
demonstrated homogenisation of ESS over 5 years, with less expo-
sure to atherogenic low ESS and increased exposure to moderate
and high ESS which are generally thought to be more atheroprotec-
tive. Critically, this was accompanied by a significant reduction in
maximum blood viscosity. Immediately after implantation, micro-
recirculation, low ESS, and high peak viscosity within the scaffolded
region may contribute to early accumulation of fibrin, platelets, and
other blood components just distal to each strut.47 In a sense, the
scaffold may act as a template for neointimal growth between struts
as these aggregated materials organize. Once neointimal tissue has
grown to cover the struts and the lumen surface becomes smooth,
the alternans of high and low ESS dissipates, overall ESS increases,
and peak viscosity is reduced. In such an ideal scenario there is no
longer strong stimulus for thrombosis or neointimal hyperplasia.
Remarkably, as bioresorbable devices dissolve, underlying arteries
have demonstrated a partial and gradual return of normal arterial vas-
oreactivity and plaque stabilisation in addition to late lumen gain.4–7
We postulate that some of these observations may be related to the
normalisation of haemodynamics after scaffold implantation.
Although none of the patients in the current study developed
adverse clinical events during 5 years of follow-up, our findings may
add to previous work in explaining certain mechanisms of scaffold
thrombosis and the potential mechanisms of long-term benefit.
Factors associated with very late scaffold thrombosis include poor
neointimal healing, uncovered struts, and persistent scaffold malap-
position.32 In some cases, suboptimal local haemodynamics immedi-
ately after scaffold implantation may contribute to poor neointimal
growth and persistently uncovered or malapposed struts.17 Such
struts protruding into the lumen are exposed to high ESS, which is
associated with platelet activation.46 Regions distal to protruding
struts are prone to low ESS and high viscosity, where activated plate-
lets can aggregate.
Non-Newtonian simulations provide uniquely complementary
haemodynamic data about blood viscosity. Blood is a non-
Newtonian fluid with primarily shear-thinning properties: at low
shear rates blood is thick, but at high shear rates it becomes thinner
with viscosity approaching a constant. Although most arterial CFD
simulations safely assume that blood behaves as a Newtonian fluid
with a constant viscosity, under certain flow conditions the local
shear rate can drop enough that the Newtonian assumption no lon-
ger holds.48–51 This appears to be the case in coronary arteries under
pulsatile flow and harbouring curvatures and scaffolds: even after
averaging viscosity throughout each entire simulated artery, relative
blood viscosity was approximately 35% greater than the Newtonian
model, a finding consistent with previous studies in unstented
arteries.29,52–54 That we have demonstrated discrete and consistent
increases in blood viscosity in patient-specific scaffolded coronary
arteries suggests that the Newtonian assumption may not always be
accurate in this setting.
The ability to measure local blood viscosity in vivo has the poten-
tial to add an entirely new dimension to the study of local arterial
haemodynamics. Although some clinical evidence points to a correla-
tion between higher plasma viscosity and coronary disease,55
whether and how local blood viscosity relates to clinical outcomes
will require much larger dedicated studies. Additionally, previous
CFD studies suggest that neglecting non-Newtonian behaviours of
blood may reduce the accuracy of ESS measurements.48–50 This may
partially explain the persistent limitation of ESS to detect and predict
progressive atherosclerosis.56 It is possible that in combination with
traditional wall-based haemodynamic metrics, non-Newtonian simu-
lations and viscosity calculations may improve the accuracy and spe-
cificity of CFD simulations by identifying areas at risk for platelet
.............................................................. .......................................................... ...........................................................
....................................................................................................................................................................................................................
Table 4 Local blood viscosity at baseline and 5 years, all cases combined
Systole Diastole Time-averaged
Baseline
(95% CI)
5 years
(95% CI)
P-value Baseline
(95% CI)
5 years
(95% CI)
P-value Baseline
(95% CI)
5 years
(95% CI)
P-value
Maximum
viscosity
8.84 ± 1.79
(4.01 to 13.70)
5.33± 3.63
(-5.31 to 13.25)
0.043 4.46± 1.50
(0.23 to 7.88)
3.18 ± 0.90
(0.58 to 5.52)
0.063 4.30± 1.54
(-0.08 to 7.82)
3.21± 0.57
(1.51 to 4.84)
0.028
Relative viscosity is expressed as a ratio of non-Newtonian viscosity to the constant Newtonian viscosity (0.0035 Pa s). Maximum viscosity values are presented as relative visco-
sity ± standard deviation.
CI, confidence interval; Pa, pascal.
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activation, blood stagnation, plaque growth, neointimal hyperplasia,
and thrombosis.
Limitations
This study has several limitations that must be acknowledged. First is
the retrospective design, which means that OCT acquisition techni-
ques to optimise arterial reconstruction were not specified in the
original protocol. Second is the low number of cases studied. This
was related to the low number of patients with serial OCT in the
original study, but also to the absence of pre-definedOCT acquisition
standards leading to several OCT studies that were suboptimal for
arterial reconstruction. Due to our strict exclusion criteria, all such
cases were excluded from CFD analysis, contributing to the low
number of cases. Despite a small sample size, the overall consistency
of our results suggests that the observations may indeed merit fur-
ther investigation through dedicated pre-specified substudies of
larger clinical device trials. Third, our analysis only included interval
changes in lumen dimensions—it did not explicitly evaluate tissue
characteristics. Quantitative OCT tissue characterisation is currently
in development, and will provide further insights into the relationship
between local haemodynamics and tissue changes in the future.57
Fourth, although differences in scaffold architecture, connector
design, and strut geometry will alter the haemodynamic micro-
environment, CFD principles are universal and remain operational in
the analysis of other scaffold designs.58 Using CFD, our group has
investigated two other scaffold designs with different strut thick-
nesses, the Mirage Bioresorbable Microfiber Scaffold (125mm) and
the ArterioSorb scaffold (95mm). In both preclinical and randomized
clinical trials, we have demonstrated that the circular struts of the
Mirage become better embedded such that the area of laminar flow
disturbances and low ESS were reduced from 49.30% in Absorb to
24.48% in Mirage (P<0.0001).59–61 In addition, using pulsatile and
non-Newtonian CFD, we have shown that the ArterioSorb scaffold
exhibits major reductions in area of low ESS area compared to
Absorb, and in fact shear stress assessment has been reported as ‘a
method to differentiate bioresorbable scaffold platforms’.58
Conclusion
In conclusion, high fidelity pulsatile non-Newtonian CFD simulations
reveal micro- and macro-level haemodynamics in scaffolded coro-
nary arteries. Early haemodynamic disturbances induced after scaffold
implantation may direct subsequent neointimal growth as the scaffold
degrades, leading to more physiological ESS, reduced peak blood vis-
cosity, and in some cases lumen enlargement. The ability to identify
intravascular regions of high blood viscosity may have implications for
further clinical characterisation of thrombosis, neointimal growth,
and vessel healing.
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Supplementary material is available at European Heart Journal online.
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